Table 1. Comparison of the reported cases of Primary extraovarian granulosa cell tumor.

ref	Age (Years)	Site	Size (cm)	Imaging	Histology	IHC	Ovaries examined & uninvolved
2	50	RP	6	Non-homogenous, multi-septate cystic mass	AGCT	NA	Yes
3	58	RP	16	Well-defined heterogenous mass with areas of necrosis	AGCT	Inhibin + EMA -	Uninvolved as per previous HP report of TAH-BSO
4	52	RP	8	Solid cystic mass	AGCT	Inhibin +, vimentin +, calretinin +, EMA -	Yes
5	55	Omentum	7	Solid cystic mass	AGCT	Inhibin +, PANCK -	Uninvolved as per previous HP report of TAH-BSO
6	62	Left FT	6	Complex cystic mass	AGCT	Inhibin + Calretinin + EMA -	Yes
7	54	RP	8.8	Large lobulated solid mass with necrosis	AGCT	Inhibin + Vimentin + EMA -	Yes
8	60	RP	11	Well-defined cystic mass	AGCT	Inhibin + EMA -	Not examined
9	45	RP		Solid cystic mass	AGCT	Inhibin +	Yes
10	69	RP	12	Solid heterogeneous mass lesion	AGCT	Inhibin + EMA -	Post TAH- BSO status. HP report NA
11	64	RP	13	Large, lobulated, heterogenous mass with cystic components	AGCT	Inhibin +	Uninvolved as per previous HP report of TAH-BSO
13	54	Mesentery	13	Solid heterogeneous mass	AGCT	Inhibin + EMA -	Yes
14	58	Broad ligament	11	Large pelvic tumor	AGCT	Inhibin + Calretinin+ CK 7	Yes
15	63	Adrenal	9	Right suprarenal mass	AGCT	NA	Yes

AGCT: Adult granulomas cell tumor, cm: centimeter, EMA: Epithelial membrane antigen, FT: Fallopian Tube, HP: Histopathology, IHC: Immunohistochemistry, NA: not available, PANCK: pancytoketatin, RP: Retroperitoneum, Ref: reference, TAH-BSO: Total abdominal hysterectomy bilateral salpingo oophorectomy, CK 7: Cytokerartin 7.